Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study. - David Tougeron, Benjamin Sueur, Aziz Zaanan, Christelle Fouchardiére, David Sefrioui, Thierry Lecomte, Gaetan Des Guetz, Vincent Hautefeuille, Valerie Moulin, Christophe Locher, Yann Touchefeu, Cedric Lecaille, Gael Goujon, Aurélie Ferru, Camille Evrard - Dissemin

Language
Login

Published in

Wiley, International Journal of Cancer, 1(147), p. 285-296, 2020

DOI: 10.1002/ijc.32879

Links

ORCID
Wiley | PDF

Tools

Export citation

Search in Google Scholar

Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study.

Journal article published in 2020 by David Tougeron, Benjamin Sueur, Aziz Zaanan, Christelle Fouchardiére, David Sefrioui, Thierry Lecomte, Gaetan Des Guetz, Vincent Hautefeuille, Valerie Moulin, Christophe Locher, Yann Touchefeu, Cedric Lecaille, Gael Goujon, Aurélie Ferru, Camille Evrard and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO